Intas Pharmaceuticals acquires Prothya Biosolutions
Acquisition
Buyer
Intas Pharmaceuticals
Target
Prothya Biosolutions
Seller
Shareholders Prothya Biosolutions
Advisory Teams
BofA Securities, Evercore
Deal Value
Undisclosed
Announcement Date
11 August 2025


